Study of Oral Squamous Cell Carcinoma with and without Oral Submucous Fibrosis.
Life Sciences -Anatomy
DOI:
https://doi.org/10.22376/ijlpr.2023.13.5.L50-L57Keywords:
Oral squamous cell carcinoma, oral submucous fibrosis, areca nut, malignant transformation, arecoline.Abstract
Oral submucous fibrosis (OSMF) is a precancerous condition associated with areca nut chewing. Arecoline which isa component of areca nut is considered a carcinogen. The OSMF in patients with oral squamous cell carcinoma (OSCC) indicatesareca nut-induced carcinogenesis. The molecular pathway for oral carcinogenesis caused by areca nut is discrete and considereda different clinicopathological entity. Thus the present study aims to study and compare the demographics, risk factors, and clinicalcharacteristics of OSCC patients with and without OSMF. It was a retrospective study done by medical record review. About 40OSCC cases were selected, of which 20 were with OSMF, and 20 were without OSMF. Demographic data, risk factors includinghistory of habits such as areca nut chewing, tobacco, etc., and clinical characteristics such as anatomical location, extent, tumorsize, and lymph node metastasis were noted, and data were analyzed. The mean age of OSCC cases with OSMF was younger thanthose without OSMF. The study groups did not observe a significant difference in habit type and duration. Most OSCC patientswith OSMF were younger than those OSCC without OSMF. The buccal mucosa was the most common anatomical locationinvolved with ulcers- proliferative growth in both study groups. The incidence of multiple sites and lymph node enlargementinvolvement is higher in OSCC without OSMF compared to those with OSMF. There was no significant difference concerninghistopathological changes between OSCC with and without the OSMF group.
References
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575-80. doi: 10.1111/j.1600-0714.2007.00582.x, PMID 17944749.
Reibel J, Gale N, Hille J, Hunt JL, Lingen M, Muller S, et al. Oral potentially malignant disorders and oral epithelial dysphasia. In: El-Nagger AK, Chan JKC, Grandis JR, Takata T, Slootweg PPJ, editors. WHO classification of head and neck tumours. 4th ed. Vol. 2017. Lyon, France: IARC; 2017. p. 4.
Wollina U, Verma SB, Ali FM, Patil K. Oral submucous fibrosis: an update. Clin Cosmet Investig Dermatol. 2015 Apr 13;8:193-204. doi: 10.2147/CCID.S80576, PMID 25914554.
National Cancer Registry Programme. Consolidated report of population-based cancer registries. Indian Council of Medical Research; 2020-2022.
Chourasia NR, Borle RM, Vastani A. Concomitant association of oral submucous fibrosis and oral squamous cell carcinoma and incidence of malignant transformation of oral submucous fibrosis in a population of central India: A retrospective study. J Maxillofac Oral Surg. 2015;14(4):902-6. doi: 10.1007/s12663-015-0760-y, PMID 26604461.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4-5):309-16. doi: 10.1016/j.oraloncology.2008.06.002, PMID 18804401.
Cui L, Cai Xinjia, Huang J, Li H, Yao Z. Molecular Mechanism of Oral submucous Fibrosis induced by Arecoline: A Literature Review. J Clin Diagn Res. 2020 Jul;14(7):ZE01-5. doi: 10.7860/JCDR/2020/44276.13856.
Sullivan RJ, Hagen EH. Psychotropic substance-seeking: evolutionary pathology or adaptation? Addiction. 2002;97(4):389-400. doi: 10.1046/j.1360-0443.2002.00024.x, PMID 11964056.
Shen YW, Shih YH, Fuh LJ, Shieh TM. Oral submucous fibrosis: a review on biomarkers, pathogenic mechanisms, and treatments. Int J Mol Sci. 2020;21(19):7231. doi: 10.3390/ijms21197231, PMID 33008091.
Saalim M, Sansare K, Karjodkar FR, Johaley S, Ali IK, Sharma SR et al. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis. J Cancer Res Ther. 2021 Oct-Dec;17(6):1510-14. doi: 10.4103/jcrt.JCRT_719_19, PMID 34916386.
Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13(6):340-1. doi: 10.1111/j.1600-0528.1985.tb00468.x, PMID 3866655.
Ray JG, Ranganathan K, Chattopadhyay A. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2):200-9. doi: 10.1016/j.oooo.2015.11.024, PMID 27422418.
Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, et al. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol. 2011;223(3):366-77. doi: 10.1002/path.2786, PMID 21171082.
Tilakaratne WM, Ekanayaka RP, Warnakulasuriya S. Oral submucous fibrosis: A historical perspective and a review on etiology and pathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(2):178-91. doi: 10.1016/j.oooo.2016.04.003, PMID 27422417.
Rangaswamy S, Chikkalingaiah RG, Sanjeevarayappa PN, Govindraju P. Carcinoma arising in the background of oral submucous fibrosis. Ann Maxillofac Surg. 2019 Jul-Dec;9(2):247-52. doi: 10.4103/ams.ams_280_18, PMID 31909002.
Chaturvedi P, Vaishampayan SS, Nair S, Nair D, Agarwal JP, Kane SV, et al. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: A clinicopathologically distinct disease. Head Neck. 2013;35(10):1404-9. doi: 10.1002/hed.23143, PMID 22972608.
Sarode SC, Sarode GS. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Med Hypotheses. 2013;81(4):540-3. doi: 10.1016/j.mehy.2013.07.001, PMID 23891040.
Guo F, Jian XC, Zhou SH, Li N, Hu YJ, Tang ZG. A retrospective study of oral squamous cell carcinomas originated from oral submucous fibrosis. Zhonghua Kou Qiang Yi Xue Za Zhi. 2011;46(8):494-7. PMID 22169748.
Vijayakumar G, Sharma G, Narwal A, Kamboj M. Broder versus Bryne’s histologic grading parameters on incision biopsy specimens: A comparative study with P53 and KI67 expression. J Oral Maxillofac Pathol. 2021 Jan-Apr;25(1):55-60. doi: 10.4103/jomfp.JOMFP_328_20. PMID 34349412.
Merchant A, Husain SS, Hosain M, Fikree FF, Pitiphat W, Siddiqui AR, et al. Paan without tobacco: an independent risk factor for oral cancer. Int J Cancer. 2000;86(1):128-31. doi: 10.1002/(sici)1097-0215(20000401)86:1<128::aid-ijc20>3.0.co;2-m, PMID 10728606.
Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;37(6):477-92. doi: 10.1016/s1368-8375(01)00003-3, PMID 11435174.
Siriwardena BSMS, Jayawardena KLTD, Senarath NH, Tilakaratne WM. An evaluation of clinical and histopathological aspects of patients with oral submucous fibrosis in the background of oral squamous cell carcinoma. Biomed Res Int. 2018;2018:Article ID 4154165. doi: 10.1155/2018/4154165, PMID 30402477.
Mohiuddin S, Fatima N, Hosein S, Hosein M. High risk of malignant transformation of oral submucous fibrosis in Pakistani females: A potential national disaster. J Park Med assoc. 2016;66:1362-6.
Acharya S, Rahman S, Hallikeri K. A retrospective study of clinicopathological features of oral squamous cell carcinoma with and without oral submucous fibrosis. J Oral Maxillofac Pathol. 2019;23(1):162. doi: 10.4103/jomfp.JOMFP_275_17, PMID 31110444.
Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 2006;42(6):561-68. doi: 10.1016/j.oraloncology.2005.08.005, PMID 16311067.
Illeperuma RP, Kim DK, Park YJ, Son HK, Kim JY, Kim J, et al. Areca nut exposure increases secretion of tumor-promoting cytokines in gingival fibroblasts that trigger DNA damage in oral keratinocytes. Int J Cancer. 2015;137(11):2545-57. doi: 10.1002/ijc.29636, PMID 26076896.
Chang MC, Wu HL, Lee JJ, Lee PH, Chang HH, Hahn LJ, et al. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem. 2004;279(49):50676-83. doi: 10.1074/jbc.M404465200, PMID 15375172.
Hsieh YP, Wu KJ, Chen HM, Deng YT. Arecoline activates latent transforming growth factor beta1 via mitochondrial reactive oxygen species in buccal fibroblasts: suppression by epigallocatechin-3-gallate. J Formos Med Assoc. 2018;117(6):527-34. doi: 10.1016/j.jfma.2017.07.003, PMID 28720506.
Rakia S, Nadia N, Rabia A, et al. Oral squamous cell carcinoma presenting at a teaching hospital of Lahore: a clinicopathologic study of 89 cases of OSCC. JPDA. 2017;26(1):1680-2292.
Schmidt Jensen J, Jakobsen KK, Mirian C, Christensen JT, Schneider K, Nahavandipour A, et al. The Copenhagen oral cavity squamous cell carcinoma database: protocol and report on establishing a comprehensive oral cavity cancer database. Clin Epidemiol. 2019;11:733-41. doi: 10.2147/CLEP.S215399, PMID 31695503.
Rakia S, Nadia N, Rabia A, et al. Oral squamous cell carcinoma: a clinicopathologic study. JPDA. 2017;5885:1680-2292:2306.
Abdul Hafeez S, Taqi M, Navid Rashid Q. Histopathological patterns of oral squamous cell carcinoma. Pak Oral Dent J. 2014;34(3):449-51.
Gadbail AR, Chaudhary M, Gawande M, Hande A, Sarode S, Tekade SA, et al. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis. J Oral Pathol Med. 2017;46(6):448-53. doi: 10.1111/jop.12553, PMID 28129456.
Singh G, Rana AS, Kumar A, Prajapati A, Kumar S, Singh P. Nodal involvement in Oral squamous cell carcinoma (SCC) patients with and without Oral Sub Mucous Fibrosis (OSMF): A Comparative Study. J Oral Biol Craniofac Res. 2017;7(3):171-77. doi: 10.1016/j.jobcr.2017.03.007, PMID 29123995.
Chaturvedi P, Vaishampayan SS, Nair S, Nair D, Agarwal JP, Kane SV, et al. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: A clinicopathologically distinct disease. Head Neck. 2013;35(10):1404-9. doi: 10.1002/hed.23143, PMID 22972608.
Zhou S, Qu X, Yu Z, Zhong L, Ruan M, Ma C, et al. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(4):575-81. doi: 10.1016/j.tripleo.2009.10.054, PMID 20303055.
Published
How to Cite
Issue
Section
Copyright (c) 2023 B H Shiny Vinila, N Vishali, Ashalata Gannepalli
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.